PNC Financial Services Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$248K Buy
2025
Q2
$162K Buy
2025
Q1
$114K Buy
2024
Q4
$138K Buy
2024
Q3
$129K Buy
2024
Q2
$8.82K Buy
2024
Q1
$5.48K Buy
2023
Q4
$213 Buy